Colin L. Hickle

Statistics

Publications

Citations

109

H-Index

Active since

2015

Affiliations

Omeros Corporation (United States)(Current)

Colin L. Hickle is an author at Omeros Corporation (United States) specializing in pharmacy, antibody conjugation, and antibody-drug conjugate linkers.

ORCID

Publications per year

2015–2021

Publications

Tandem-Cleavage Linkers Improve the In Vivo Stability and Tolerability of Antibody–Drug Conjugates

Stepan Chuprakov, Ayodele O. Ogunkoya, Robyn M. Barfield et al. · Bioconjugate Chemistry · 2021 · 69 citations

Pharmacy, Pharmaceutics, Pharmacology +17

A CpG-Ficoll Nanoparticle Adjuvant for Anthrax Protective Antigen Enhances Immunogenicity and Provides Single-Immunization Protection against Inhaled Anthrax in Monkeys

Melissa A. Kachura, Colin L. Hickle, Sariah Kell et al. · The Journal of Immunology · 2015 · 27 citations · Full text

Pharmacy, Biotechnology, Immunology +17

A Novel HER2-targeted Antibody–drug Conjugate Offers the Possibility of Clinical Dosing at Trastuzumab-equivalent Exposure Levels

Robyn M. Barfield, Yun Cheol Kim, Stepan Chuprakov et al. · Molecular Cancer Therapeutics · 2020 · 13 citations · Full text

Pharmacy, Oncology, Pharmacology +17

1–3 of 3